10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
CIGNA CORP | |||
Ticker: CI Fiscal Year: 2009 | |||
Consolidated Statements of Income | |||
Period Ending Dec 31, 2009 10-K (Filed: Feb 25, 2010) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2009 | Dec 31, 2008 | Dec 31, 2007 | |
| Revenues | |||
| Premiums and fees | $ 16,041 | 16,253 | 15,008 |
| Net investment income | 1,014 | 1,063 | 1,114 |
| Mail order pharmacy revenues | 1,282 | 1,204 | 1,118 |
| Other revenues | 120 | 751 | 368 |
| Realized investment gains (losses): | |||
| Other than temporary impairments on debt securities, net | (47) | (213) | (31) |
| Other realized investment gains | 4 | 43 | 47 |
| Total realized investment gains (losses) | (43) | (170) | 16 |
| Total revenues | 18,414 | 19,101 | 17,624 |
| Benefits and Expenses | |||
| Health Care medical claims expense | 6,927 | 7,252 | 6,798 |
| Other benefit expenses | 3,407 | 4,285 | 3,401 |
| Mail order pharmacy cost of goods sold | 1,036 | 961 | 904 |
| Guaranteed minimum income benefits (income) expense | (304) | 690 | 147 |
| Other operating expenses | 5,450 | 5,531 | 4,740 |
| Total benefits and expenses | 16,516 | 18,719 | 15,990 |
| Income from Continuing Operations before Income Taxes | 1,898 | 382 | 1,634 |
| Income taxes (benefits): | |||
| Current | 275 | 313 | 511 |
| Deferred | 319 | (221) | 0 |
| Total taxes | 594 | 92 | 511 |
| Income from Continuing Operations | 1,304 | 290 | 1,123 |
| Income (loss) from Discontinued Operations, Net of Taxes | 1 | 4 | (5) |
| Net Income | 1,305 | 294 | 1,118 |
| Less: Net Income Attributable to Noncontrolling Interest | 3 | 2 | 3 |
| Shareholders' Net Income | 1,302 | 292 | 1,115 |
| Basic Earnings Per Share: | |||
| Shareholders' income from continuing operations | 4.75 | 1.04 | 3.91 |
| Shareholders' income (loss) from discontinued operations | 0.00 | 0.01 | (0.02) |
| Shareholders' net income | 4.75 | 1.05 | 3.89 |
| Diluted Earnings Per Share: | |||
| Shareholders' income from continuing operations | 4.73 | 1.03 | 3.86 |
| Shareholders' income (loss) from discontinued operations | 0.00 | 0.02 | (0.02) |
| Shareholders' net income | 4.73 | 1.05 | 3.84 |
| Dividends Declared Per Share | 0.04 | 0.04 | 0.04 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
CIGNA CORP | |||
Ticker: CI Fiscal Year: 2009 | |||
Consolidated Statements of Cash Flows | |||
Period Ending Dec 31, 2009 10-K (Filed: Feb 25, 2010) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2009 | Dec 31, 2008 | Dec 31, 2007 | |
| Cash Flows from Operating Activities | |||
| Net income | $ 1,305 | 294 | 1,118 |
| Adjustments to reconcile net income to net cash provided by operating activities: | |||
| (Income) loss from Discontinued Operations | (1) | (4) | 5 |
| Insurance liabilities | (357) | 485 | (24) |
| Reinsurance recoverables | 30 | 63 | 159 |
| Deferred policy acquisition costs | (109) | (74) | (106) |
| Premiums, accounts and notes receivable | 49 | 219 | 47 |
| Other assets | 452 | (860) | (134) |
| Accounts payable, accrued expenses and other liabilities | (1,321) | 1,466 | 150 |
| Current income taxes | 55 | (72) | 10 |
| Deferred income taxes | 319 | (221) | 0 |
| Realized investment (gains) losses | 43 | 170 | (16) |
| Depreciation and amortization | 268 | 244 | 194 |
| Gains on sales of businesses (excluding discontinued operations) | (32) | (38) | (47) |
| Mortgage loans originated and held for sale | 0 | 0 | (80) |
| Proceeds from sales of mortgage loans held for sale | 1 | 1 | 76 |
| Other, net | 43 | (17) | (10) |
| Net cash provided by operating activities | 745 | 1,656 | 1,342 |
| Cash Flows from Investing Activities | |||
| Proceeds from investments sold: | |||
| Proceeds from investments sold, Fixed maturities | 927 | 1,459 | 1,012 |
| Proceeds from investments sold, Equity securities | 22 | 6 | 28 |
| Proceeds from investments sold, Commercial mortgage loans | 61 | 48 | 1,293 |
| Proceeds from investments sold, Other (primarily short-term and other long-term investments) | 910 | 492 | 260 |
| Investment maturities and repayments: | |||
| Investment maturities and repayments, Fixed maturities | 1,100 | 872 | 973 |
| Investment maturities and repayments, Commercial mortgage loans | 94 | 98 | 123 |
| Investments purchased: | |||
| Investments purchased, Fixed maturities | (2,916) | (2,681) | (2,150) |
| Investments purchased, Equity securities | (14) | (18) | (27) |
| Investments purchased, Commercial mortgage loans | (175) | (488) | (693) |
| Investments purchased, Other (primarily short-term and other long-term investments) | (1,187) | (776) | (394) |
| Property and equipment sales | 0 | 0 | 82 |
| Property and equipment purchases | (307) | (257) | (262) |
| Acquisition of Great-West Healthcare, net of cash acquired | 0 | (1,319) | 0 |
| Cash provided by investing activities of discontinued operations | 0 | 0 | 70 |
| Other (primarily other acquisitions/dispositions) | 0 | (8) | (46) |
| Net cash provided by (used in) investing activities | (1,485) | (2,572) | 269 |
| Cash Flows from Financing Activities | |||
| Deposits and interest credited to contractholder deposit funds | 1,312 | 1,305 | 1,175 |
| Withdrawals and benefit payments from contractholder deposit funds | (1,223) | (1,214) | (1,368) |
| Change in cash overdraft position | 53 | (17) | (20) |
| Net change in short-term debt | (199) | 298 | 0 |
| Net proceeds on issuance of long-term debt | 346 | 297 | 498 |
| Repayment of long-term debt | (1) | 0 | (378) |
| Repurchase of common stock | 0 | (378) | (1,185) |
| Issuance of common stock | 30 | 37 | 248 |
| Common dividends paid | (11) | (14) | (11) |
| Net cash provided by (used in) financing activities | 307 | 314 | (1,041) |
| Effect of foreign currency rate changes on cash and cash equivalents | 15 | (26) | 8 |
| Net increase (decrease) in cash and cash equivalents | (418) | (628) | 578 |
| Cash and cash equivalents, beginning of period | 1,342 | 1,970 | |
| Cash and cash equivalents, end of period | 924 | 1,342 | 1,970 |
| Supplemental Disclosure of Cash Information: | |||
| Income taxes paid, net of refunds | 220 | 366 | 455 |
| Interest paid | 158 | 140 | 122 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
CIGNA CORP | ||
Ticker: CI Fiscal Year: 2009 | ||
Consolidated Balance Sheets | ||
Period Ending Dec 31, 2009 10-K (Filed: Feb 25, 2010) | ||
| (In Millions, except shares in actual) | ||
| As of | As of | |
| Dec 31, 2009 | Dec 31, 2008 | |
| Assets | ||
| Investments: | ||
| Fixed maturities, at fair value (amortized cost, $12,580; $11,492) | $ 13,443 | 11,781 |
| Equity securities, at fair value (cost, $137; $140) | 113 | 112 |
| Commercial mortgage loans | 3,522 | 3,617 |
| Policy loans | 1,549 | 1,556 |
| Real estate | 124 | 53 |
| Other long-term investments | 595 | 632 |
| Short-term investments | 493 | 236 |
| Total investments | 19,839 | 17,987 |
| Cash and cash equivalents | 924 | 1,342 |
| Accrued investment income | 238 | 225 |
| Premiums, accounts and notes receivable, net | 1,361 | 1,407 |
| Reinsurance recoverables | 6,597 | 6,973 |
| Deferred policy acquisition costs | 943 | 789 |
| Property and equipment | 862 | 804 |
| Deferred income taxes, net | 1,029 | 1,617 |
| Goodwill | 2,876 | 2,878 |
| Other assets, including other intangibles | 1,056 | 1,520 |
| Separate account assets | 7,288 | 5,864 |
| Total assets | 43,013 | 41,406 |
| Liabilities | ||
| Contractholder deposit funds | 8,484 | 8,539 |
| Future policy benefits | 8,136 | 8,754 |
| Unpaid claims and claim expenses | 3,968 | 4,037 |
| Health Care medical claims payable | 921 | 924 |
| Unearned premiums and fees | 427 | 414 |
| Total insurance and contractholder liabilities | 21,936 | 22,668 |
| Accounts payable, accrued expenses and other liabilities | 5,797 | 6,869 |
| Short-term debt | 104 | 301 |
| Long-term debt | 2,436 | 2,090 |
| Nonrecourse obligations | 23 | 16 |
| Separate account liabilities | 7,288 | 5,864 |
| Total liabilities | 37,584 | 37,808 |
| Contingencies - Note 23 | -- | -- |
| Shareholders' Equity | ||
| Common stock (par value per share, $0.25; shares issued, 351) | 88 | 88 |
| Additional paid-in capital | 2,514 | 2,502 |
| Net unrealized appreciation (depreciation), fixed maturities | 378 | (147) |
| Net unrealized appreciation, equity securities | 4 | 7 |
| Net unrealized depreciation, derivatives | (30) | (13) |
| Net translation of foreign currencies | (12) | (60) |
| Postretirement benefits liability adjustment | (958) | (861) |
| Accumulated other comprehensive loss | (618) | (1,074) |
| Retained earnings | 8,625 | 7,374 |
| Less treasury stock, at cost | (5,192) | (5,298) |
| Total shareholders' equity | 5,417 | 3,592 |
| Noncontrolling interest | 12 | 6 |
| Total equity | 5,429 | 3,598 |
| Total liabilities and equity | 43,013 | 41,406 |
| Shareholders' Equity Per Share | 19.75 | 13.25 |
| External Links | |
| CIGNA CORP (CI) Fiscal Year 2009 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |